浏览全部资源
扫码关注微信
1.中国药科大学基础医学与临床药学学院,南京 210009
2.加拿大滑铁卢大学药学院,加拿大 安大略省 N2L 3G1
Published:30 October 2024,
Received:27 February 2024,
Revised:21 September 2024,
移动端阅览
胡源晖,李果霖,Feng Chang等.我国社区药师对慢性疾病患者药学服务的范围综述 Δ[J].中国药房,2024,35(20):2559-2564.
HU Yuanhui,LI Guolin,FENG Chang,et al.Scoping review of pharmaceutical service provided by community pharmacists for patients with chronic diseases in China[J].ZHONGGUO YAOFANG,2024,35(20):2559-2564.
胡源晖,李果霖,Feng Chang等.我国社区药师对慢性疾病患者药学服务的范围综述 Δ[J].中国药房,2024,35(20):2559-2564. DOI: 10.6039/j.issn.1001-0408.2024.20.20.
HU Yuanhui,LI Guolin,FENG Chang,et al.Scoping review of pharmaceutical service provided by community pharmacists for patients with chronic diseases in China[J].ZHONGGUO YAOFANG,2024,35(20):2559-2564. DOI: 10.6039/j.issn.1001-0408.2024.20.20.
目的
2
总结和分析我国社区药师实施慢性疾病(以下简称“慢病”)药学服务的概况。
方法
2
检索中国知网、万方数据、PubMed(Medline)、Embase和Scopus数据库等,收集社区药师为慢病患者提供药学服务的研究,描述性总结社区药师实施慢病药学服务的方式与内容。
结果
2
共纳入75项研究,包括49项试验研究和26项横断面研究。研究地点主要分布在我国经济较发达地区,研究涉及的患者疾病类型主要为糖尿病(
n
=31)和高血压(
n
=28),多数研究采用疾病症状及相关指标变化情况(
n
=35)、患者依从性改善情况(
n
=34)、药物不良反应(不合理用药)发生情况(
n
=25)等评价药学服务。社区药师向慢病患者提供的药学服务项目包括用药教育(84.0%)、监测与随访(64.0%)、识别和解决药物相关问题(58.7%)等。38项研究提及药学服务是通过团队合作实现的,其中16项研究提到了医联体。少数研究报道了分层诊疗服务(
n
=15)和基于互联网的药学服务(
n
=10)。
结论
2
在我国,社区药师为慢病患者提供的药学服务仍主要局限于经济较发达地区,且服务范围局限于少数疾病和基本药学实践。在未来,针对不同疾病及患者疾病状态实施精准药学服务、建立基层医联体及开展互联网药学服务,应成为药学服务的重点。
OBJECTIVE
2
To summarize and analyze the profile of the implementation of pharmaceutical service by community pharmacists for patients with chronic diseases in China.
METHODS
2
Literature was searched from CNKI, Wanfang database, PubMed (Medline), Embase, and Scopus to collect studies about community pharmacists providing pharmaceutical services for patients with chronic diseases. The ways and contents of the implementation of pharmaceutical services for chronic diseases by community pharmacists were summarized descriptively.
RESULTS
2
A total of 75 studies were included, involving 49 trial studies and 26 cross-sectional studies. The study sites were mainly located in the developed regions of China, and the types of disease involved in the studies were mainly diabetes mellitus (
n
=30) and hypertension (
n
=28); most studies used the following indexes to evaluate pharmaceutical services, such as changes in disease symptoms and related indicators(
n
=35), improvement of patient compliance(
n
=34), and the occurrence of adverse drug reactions (irrational drug use) (
n
=25). The pharmaceutical service provided by community pharmacists included medication education (84.0%), monitoring and follow-up (64.0%), and identifying and solving medication-related problems (58.7%). Thirty-eight studies mentioned that pharmaceutical services were achieved through teamwork, 16 of which mentioned healthcare alliances. A few studies investigated stratified healthcare systems (
n
=15) and internet-based pharmaceutical services (
n
=10).
CONCLUSIONS
2
In China, pharmaceutical services provided by community pharmacies for patients with chronic diseases are still mainly confined to economically developed areas, and the scope of services is limited to a few diseases and basic pharmaceutical practices. In the future, the implementation of precise pharmaceutical services for different diseases and patients’ disease status, the establishment of medical alliances, and the development of internet-based pharmaceutical services should become the focus of pharmaceutical services.
社区药师社区药房慢性疾病药学服务
community pharmacychronic diseasepharmaceutical service
BONVENTO G,CHARBONNÉ R,CORRÈZE J L,et al. Is alpha-chloralose plus halothane induction a suitable anesthetic regimen for cerebrovascular research?[J]. Brain Res,1994,665(2):213-221.
MANOLAKIS P G,SKELTON J B. Pharmacists’ contributions to primary care in the United States collaborating to address unmet patient care needs:the emerging role for pharmacists to address the shortage of primary care providers[J]. Am J Pharm Educ,2010,74(10):S7.
WANG X,SUN X Z,BIRCH S,et al. People-centred integrated care in urban China[J]. Bull World Health Organ,2018,96(12):843-852.
HASHMI F K,HASSALI M A,KHALID A,et al. A qualitative study exploring perceptions and attitudes of community pharmacists about extended pharmacy services in Lahore,Pakistan[J]. BMC Health Serv Res,2017,17(1):500.
TRICCO A C,LILLIE E,ZARIN W,et al. PRISMA extension for scoping reviews(PRISMA-ScR):checklist and explanation[J]. Ann Intern Med,2018,169(7):467-473.
罗伯特·J·奇波利,琳达·M·斯特兰德,彼得·C·莫利.药学监护实践方法:以患者为中心的药物治疗管理服务[M]. 康震,金有豫,朱珠,等译.北京:化学工业出版社,2016:38-40.
ROBERT J C,LINDA M S,PETER C M. Pharmaceutical care practice:the patient-centered approach to medication management services[M]. KANG Z,JIN Y Y,ZHU Z,et al translated. Beijing:Chemical Industry Press,2016:38-40.
CHEN L,LIU Y Y,XI X Y. Study of knowledge,attitude and practice regarding patient education in hypertension among community pharmacists in China[J]. BMC Health Serv Res,2022,22(1):1295.
WANG J,PEI Y Y,YU F,et al. Understandings,attitudes,and barriers about diabetes care:analysis of factors influen-cing community pharmacists in China[J]. Diabetes Metab Syndr Obes,2021,14:1999-2009.
沈美,顾洪安,王忠壮. 上海市首批社区临床药师规范化培训后药学服务的现况[J]. 药学服务与研究,2018,18(4):265-269.
SHEN M,GU H A,WANG Z Z. The present status of pharmaceutical care provided by community clinical pharmacists after first round of standardized training in Shanghai[J]. Pharm Care Res,2018,18(4):265-269.
黄宇虹,谢根英,许惠溢,等. 厦门市海沧区药事综合管理体系的建立与社区卫生服务中心药学发展[J]. 海峡药学,2022,34(10):133-136.
HUANG Y H,XIE G Y,XU H Y,et al. Establishment of pharmaceutical management system and pharmaceutical development of community health service center in Haicang District of Xiamen[J]. Strait Pharm J,2022,34(10):133-136.
沈江华,王淑洁,曾艳,等. 基于9省(区、市)调查的全国基层药学人员药学服务现状及其培训需求研究[J]. 中国药房,2018,29(6):843-847.
SHEN J H,WANG S J,ZENG Y,et al. Status quo of pharmaceutical care and training needs research of primary pharmaceutical staff based on 9 provinces(regions,cities)investigation[J]. China Pharm,2018,29(6):843-847.
王一琳. 武汉市社区卫生服务机构药学服务提供现状及综合评价研究[D]. 武汉:华中科技大学,2020.
WANG Y L. Study on the present situation and comprehensive evaluation of pharmaceutical service provision in community health service institutions in Wuhan[D]. Wuhan:Huazhong University of Science and Technology,2020.
乔曼华,吴文辉,刘真伟,等. 上海市社区药学服务开展现状[J]. 中国全科医学,2022,25(28):3562-3568.
QIAO M H,WU W H,LIU Z W,et al. Community pharmaceutical services implemented in Shanghai[J]. Chin Gen Pract,2022,25(28):3562-3568.
莫豪行,刘晓青,官昌. 药师参与家庭医生团队对社区慢病患者药学服务的实践[J]. 中国处方药,2021,19(6):50-52.
MO H X,LIU X Q,GUAN C. Practice of pharmacists participating in family doctor team’s pharmaceutical care for community chronic patients[J]. J China Prescr Drug,2021,19(6):50-52.
刘巧珍,王妍,姬利红. 区域临床药师协同参与社区高血压慢病管理的效果评价[J]. 中国药物滥用防治杂志,2021,27(3):376-380.
LIU Q Z,WANG Y,JI L H. Effect evaluation of the coo-perative participation in hypertension chronic disease management of regional clinical pharmacists[J]. Chin J Drug Abuse Prev Treat,2021,27(3):376-380.
张谢稍,邓海峰,陈耀宗. 社区药师对糖尿病患者进行家庭用药指导的效果分析[J]. 中国现代药物应用,2021,15(1):236-238.
ZHANG X S,DENG H F,CHEN Y Z. Effect analysis of family medication guidance for patients with diabetes mellitus by community pharmacists[J]. Chin J Mod Drug Appl,2021,15(1):236-238.
邹绮雯,王晓聪,曾芬娜,等. 浅谈临床药师加入家庭医生团队的作用[J]. 中国合理用药探索,2020,17(5):34-37.
ZOU Q W,WANG X C,ZENG F N,et al. Role of clinical pharmacists joining the family doctor team[J]. Chin J Ration Drug Use,2020,17(5):34-37.
万晓峰. 全程化药学服务对社区慢性病患者用药的影响作用分析[J]. 海峡药学,2020,32(2):169-170.
WAN X F. Analysis of the influence of whole-course pharmaceutical care on the medication of patients with chronic diseases in community[J]. Strait Pharm J,2020,32(2):169-170.
吴燕,李春燕. 签约居民居家药学服务模式及其应用效果[J]. 现代养生,2023,23(19):1512-1514.
WU Y,LI C Y. Home pharmaceutical service mode of contracted residents and its application effect[J]. Health Prot Promot,2023,23(19):1512-1514.
武明芬,马力,国警月,等. 社区慢病药物治疗管理服务模式探索与实践[J]. 医药导报,2023,42(6):912-917.
WU M F,MA L,GUO J Y,et al. Exploration and practice of a new service model of medication therapy management on community chronic disease[J]. Her Med,2023,42(6):912-917.
杨涛,刘彦儒,朱亚虹,等. 区域中心医院与社区医院临床药师协同管理门诊糖尿病病人效果分析[J]. 安徽医药,2023,27(5):1048-1053.
YANG T,LIU Y R,ZHU Y H,et al. Effect of cooperative management of outpatient diabetes patients by clinical pharmacists in regional central hospital and community hospital[J]. Anhui Med Pharm J,2023,27(5):1048-1053.
万素馨,方伟,孙秋艳. “互联网+医联体” 一体化药学服务体系的构建及实践[J]. 中国药房,2019,30(23):3199-3204.
WAN S X,FANG W,SUN Q Y. Construction and practice of integrated pharmaceutical care system of“Internet + medical consortium”[J]. China Pharm,2019,30(23):3199-3204.
NIQUILLE A,LATTMANN C,BUGNON O. Medication reviews led by community pharmacists in Switzerland:a qualitative survey to evaluate barriers and facilitators[J]. Pharm Pract,2010,8(1):35-42.
SMITH M. Primary care pharmacist services align with payment reform and provider “joy of practice”[J]. Ann Pharmacother,2019,53(3):311-315.
杨心玫,申卫星. 药师立法中的药事服务费问题研究[J]. 中国卫生产业,2019,16(17):94-98,147.
YANG X M,SHEN W X. Study on the pharmacy service fee in the pharmacist legislation[J]. China Health Ind,2019,16(17):94-98,147.
范蒋青,申越,程京格,等. 南京市主城区社区卫生服务中心药学服务现状调研[J]. 医药导报,2023,42(11):1697-1703.
FAN J Q,SHEN Y,CHENG J G,et al. Investigation on the current situation of pharmaceutical care in community health service centers of urban districts of Nanjing City[J]. Her Med,2023,42(11):1697-1703.
吴文辉,杨燕,唐密,等. 上海市社区临床药师能力提升模式与建设现状[J]. 世界临床药物,2021,42(1):21-24,45.
WU W H,YANG Y,TANG M,et al. The mode of ability promotion and current situation of capacity building on community clinical pharmacist in Shanghai[J]. World Clin Drugs,2021,42(1):21-24,45.
NILOVSKAIA I S. Effect of hypo- and hyperglycemic conditions on the development of chloral hydrate induced sleep[J]. Farmakol Toksikol,1957,20(3):38-42.
柴林巧,杨晓云,朱丹萍,等. 新型社区药学服务体系对高血压和糖尿病干预效果评价[J]. 浙江中西医结合杂志,2017,27(3):247-248.
CHAI L Q,YANG X Y,ZHU D P,et al. Evaluation of intervention effect of new community pharmaceutical service system on hypertension and diabetes mellitus[J]. Zhejiang J Integr Tradit Chin West Med,2017,27(3):247-248.
TANG Q,WAN L T,LU J,et al. Rational medication mana-gement mode and its implementation effect for the elderly with multimorbidity:a prospective cohort study in China[J]. Front Public Health,2022,10:992959.
胡琦,吴方,任旭,等. 美国、加拿大两国以患者为中心的基层卫生服务模式比较与启示[J]. 中国社会医学杂志,2023,40(2):204-208.
HU Q,WU F,REN X,et al. A comparative study of patient-centered primary health care model in the US and Canada and its implications[J]. Chin J Soc Med,2023,40(2):204-208.
董红妮,曹红,林筱琦,等. 新疆医院精准药学服务现状调研[J]. 中国药业,2023,32(10):31-34.
DONG H N,CAO H,LIN X Q,et al. Investigation on the current status of precision pharmaceutical care in Xinjiang hospitals[J]. China Pharm,2023,32(10):31-34.
朱可喻,俞越峰,袁天宜,等. 上海市黄浦区社区卫生服务中心临床药师药学服务现状调查[J]. 上海医药,2021,42(4):9-12.
ZHU K Y,YU Y F,YUAN T Y,et al. Investigation of current status of pharmaceutical service of clinical pharmacists in the community health service centers of Huangpu District,Shanghai[J]. Shanghai Med Pharm J,2021,42(4):9-12.
SAW P S,NISSEN L,FREEMAN C,et al. A qualitative study on pharmacists’ perception on integrating pharmacists into private general practitioner’s clinics in Malaysia[J]. Pharm Pract,2017,15(3):971.
TAN E C,STEWART K,ELLIOTT R A,et al. Stakeholder experiences with general practice pharmacist services:a qualitative study[J]. BMJ Open,2013,3(9):e003214.
宋碧辉,余江恒,杨光丽,等. 医联体建设中一体化药学服务模式的建立及应用研究[J]. 中国药业,2021,30(11):5-8.
SONG B H,YU J H,YANG G L,et al. Establishment and application of integrated pharmaceutical care model in the construction of a medical consortium[J]. China Pharm,2021,30(11):5-8.
李桃园,张楠,杨啸白,等. 北京市朝阳区南部医联体糖尿病用药风险防范模式探索[J]. 临床药物治疗杂志,2016,14(6):45-48.
LI T Y,ZHANG N,YANG X B,et al. Exploration on working mode regarding risks prevention of diabetes mellitus medication in community healthcare centers of sou-thern Chaoyang District[J]. Clin Med J,2016,14(6):45-48.
American Pharmacists Association,National Association of Chain Drug Stores Foundation. Medication therapy management in community pharmacy practice:core elements of an MTM service(version 1.0)[J]. J Am Pharm Assoc,2005,45(5):573-579.
BENNETT M,GOODE J V R. Recognition of community-based pharmacist practitioners:essential health care providers[J]. J Am Pharm Assoc,2016,56(5):580-583.
BROWN L,SEOANE-VAZQUEZ E. Pharmaceutical care in North America[M]//The Pharmacist Guide to Implementing Pharmaceutical Care. Cham:Springer International Publishing,2018:145-158.
冯荣楷,孟丽荣,王乾韬,等. 英格兰社区药房服务及其对中国社会药房发展的启示[J]. 中国药房,2011,22(44):4215-4218.
FENG R K,MENG L R,WANG Q T,et al. Inspiration of the England community pharmacy services for the deve-lopment of pharmacy in China[J]. China Pharm,2011,22(44):4215-4218.
李思聪,聂小燕,韩晟,等. 我国互联网+背景下医院O2O药学服务模式发展研究[J]. 中国药房,2021,32(4):496-501.
LI S C,NIE X Y,HAN S,et al. Research on the development of O2O pharmaceutical care mode in China under the Internet plus background[J]. China Pharm,2021,32(4):496-501.
CHEN H H,SHAO R,XIONG Y Q,et al. Participation of pharmacists and patients in web-based pharmaceutical care consultation based on MEDICODE[J]. Int J Med Inform,2023,175:105074.
王杨. 基于“互联网+” 的便民型智能基层零售药店经营模式探索[J]. 现代商业,2018(31):28-29.
WANG Y. Exploration on the business model of convenient intelligent primary retail pharmacy based on “Internet plus” [J]. Mod Bus,2018(31):28-29.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution